Brief: Zydus Lifesciences Says USFDA Inspection Closed With 2 Observations For Ankleshwar Unit-2 Plant
Jan 23 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: USFDA INSPECTION CLOSED AT ZYDUS UNIT-2 PLANT IN ANKLESHWAR INSPECTION CONCLUDED WITH 3 OBSERVATIONS Source text: ID:nBSE42WxM Further company coverage: ZYDU.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka